Shopping Cart
- Remove All
- Your shopping cart is currently empty
IX-207-887 is an innovative anti-arthritis compound that effectively inhibits the release of interleukin-1 (IL-1) from human monocytes and murine peritoneal macrophages in vitro. Its active concentration can reach therapeutic levels in both human rheumatoid arthritis and animal arthritis models. Furthermore, IX-207-887 exhibits a novel ability to suppress IL-1 release.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | IX-207-887 is an innovative anti-arthritis compound that effectively inhibits the release of interleukin-1 (IL-1) from human monocytes and murine peritoneal macrophages in vitro. Its active concentration can reach therapeutic levels in both human rheumatoid arthritis and animal arthritis models. Furthermore, IX-207-887 exhibits a novel ability to suppress IL-1 release. |
Alias | IX 207-887 |
Molecular Weight | 284.33 |
Formula | C16H12O3S |
Cas No. | 128439-98-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.